Source: DGNews | Posted 9 years ago
FDA Approves Prandin (Repaglinide) in Combination With Insulin Sensitizers for Type 2 Diabetes
Tags:
Studies Show Greater Glycemic Improvements With Prandin and Sensitizers Compared to Monotherapy in Treating Type 2 Diabetes
PRINCETON, NJ -- October 22, 2002 -- Novo Nordisk announced today that the U.S. Food and Drug Administration (FDA) approved a new indication for use of the oral antidiabetic drug (OAD) Prandin
Comments